Search
Enter keywords, a title or a report id number below.
Your Search for 'Attitudes Towards Health & Pharmaceuticals in the United States 2005' returned 13 results - Page 1 of 1
Sort by
Sorted by
Rank
Top-Bottom
-
Consumer Lifestyles In The United Kingdom
Euromonitor International, Feb 2012 , Pages: 97back into consumers' lives. In 2010, the Misery Index was comparable to the US but far lower than that of countries like Spain. Euromonitor's Consumer Lifestyles in the United Kingdom report analyses ... -
The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers
Scripp Business Insights, Nov 2009 , Pages: 137Regulatory drivers European regulation Short term pain should give way to longer term benefits US regulation US regulation is currently under review Japanese regulation Regulation has helped to establish ... -
The Global Market for AntiMicrobials and Antifungals; Challenging Resistance to 2015
Spectra Intelligence, Dec 2006 , Pages: 329reducing antibiotic usage. The total worldwide market for antibiotics and antifungals was US$25 billion in 2005, but is predicted to fall to between US$15 and US$20 billion by 2016. This forecast is based on ... -
Switzerland Pharmaceuticals and Healthcare Report Q4 2012
Business Monitor International, Mar 2012 , Pages: 83Switzerland, BMI believes the government needs to do more to alter patients' attitudes towards these drugs as this the main deterrent of growth. Headline Expenditure Projections: - Pharmaceuticals ... -
OTC Pharmaceuticals Market Report 2010
Key Note Publications Ltd, Feb 2010 , Pages: 119Total UK Market for Pharmaceuticals by Value (£m at rsp), 2005-2009 Table 1.9: The Leading Five Pharmaceutical/Biotechnology Companies by Investment in Research and Development in the UK (£m and %), 2007 ... -
Opticians & Optical Goods Market Assessment 2008
Key Note Publications Ltd, Aug 2008 , Pages: 141; Safilo; Silhouette; and the UK-based Norville. Changes made in 2005 to the 1989 UK Opticians Act — which allowed contact lenses to be supplied under the `general direction' of a qualified practitioner ... -
OTC Distribution in Europe: Entering a new Era - New Expanded 2012 Edition
James Dudley Management, Nov 2011PATIENT NEEDS CELESIO’S NEW VISION FOR PHARMACEUTICAL WHOLESALING IN EUROPE Chapter 3 CELESIO - PHARMACEUTICAL BUSINESS IN EUROPE AND BRAZIL Table 1: Celesio Consolidated Sales & Profits (€000) 2010 ... -
2008 Supplement Business Report
Nutrition Business Journal, Jun 2008 , Pages: 475. Contrasting European and American Specialty Supplement Markets 10. CONDITION SPECIFIC MARKETS 1.1. CONDITION SPECIFIC SUPPLEMENT OVERVIEW 1.2. GENERAL HEALTH 1.3. COLD/FLU-IMMUNE 1.4. SPORTS/ENERGY/WEIGHT ... -
Rural Economy Market Assessment 2009
Key Note Publications Ltd, Jan 2009 , Pages: 252agrochemicals and seeds commerce is mainly in the hands of conglomerates, which in many cases are US based. Agricultural commodity purchase and processing is also concentrated in the hands of global companies ... -
Australia Pharmaceuticals and Healthcare Report Q2 2008
Business Monitor International, May 2008 , Pages: 88, followed by neurology and analgesia. Similarly, public attitudes towards biotechnology are also improving. The results of a survey published in August 2007 found that the support for using gene technology ... -
Generics in the Animal Health Industry
Informa Healthcare, Jan 2006 , Pages: 138, such as North America and the EU, only have a share of approximately one third. In recent years, the structure of the world animal health market has altered dramatically and the industry has ... -
Healthcare Market Review 2005
Key Note Publications Ltd, Sep 2005Healthcare Market Review 2005 This Market Review analyses the healthcare market in the UK, which can be divided broadly into public healthcare (the NHS, which comprises hospital and community health ... -
OTC Pharmaceuticals Market Report 2005
Key Note Publications Ltd, Dec 2005 , Pages: 192OTC Pharmaceuticals Market Report 2005 It is estimated that, in 2005, the total UK over-the-counter (OTC) pharmaceuticals market will be worth £2.1bn at retail selling prices (rsp), a rise of 3.7% on ...
Results:
First - Prev -
1 -
Next - Last
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network